DRUG · Unmapped registry intervention
HDM1002 100 mg QD 12weeks
Find medicine records ·
Find other trials using this name
Clinical trial
HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects
NCT06520540
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
HDM1002 200 mg QD 12weeks
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
HDM1002 400 mg QD 12weeks，Q 2W for titration
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
HDM1002 400 mg QD 12weeks，Q 3W for titration
Find medicine records ·
Find other trials using this name
DEVICE · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedHDM1002 Tablets in Chinese Overweight and Obese Adult Subjects
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06520540 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.